The disinfection cap industry share is estimated to clock a revenue of US$ 376.8 million in 2024. Key players of the disinfection cap can expect a modest CAGR of 4.5% through 2034, with a forecast valuation of US$ 585.1 million by 2034.
Healthcare-acquired infections (HAIs) affect millions of people annually, contributing to considerable healthcare costs. To reduce these expenses, healthcare providers are extensively deploying disinfection caps. Moreover, the elderly population is at a higher risk of acquiring these infections due to their weakened immune systems. Therefore, countries dense with geriatric populations are more likely to invest heavily in sterile cap solutions to protect their citizens from HAIs.
New technological advancements in disinfection caps to match the current requirements of healthcare professionals are anticipated to raise the market value. Recent developments include needleless caps, antimicrobial coatings, and extended dwell caps.
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2024) | US$ 376.8 million |
Market Size (2034) | US$ 585.1 million |
Estimated Growth (2024 to 2034) | 4.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Details |
---|---|
Disinfection Cap Market Size (2019) | US$ 315.7 million |
Disinfection Cap Market Value (2023) | US$ 369.3 million |
Historical Growth Rate % (2019 to 2023) | 4% |
The disinfection cap market extrapolated from US$ 315.7 million in 2019 to US$ 369.3 million in 2023. Meanwhile, the market experienced a CAGR of 4%. Top factors that have been fueling the sales of disinfection caps are as follows:
Disinfection cap sales are projected to swing up from US$ 376.8 million in 2024 to US$ 585.1 million by 2034. FMI analysts have estimated that the market is anticipated to observe a CAGR of 4.5% throughout this period. An increase in CAGR over the forecast period indicates that the market is anticipated to flourish in upcoming years.
The rise in global population, lifestyle changes, and surging hospitalizations are, in combination, projected to increase the market value. Core factors raising the disinfection cap market value are mentioned below:
Historical CAGR % (2019 to 2023) | 4% |
---|---|
Forecast CAGR % (2024 to 2034) | 4.5% |
Country | The United States |
---|---|
Forecast CAGR % (2024 to 2034) | 4.1% |
The United States disinfection cap market holds a prominent position in North America as well as internationally. As per the latest market estimates, the country is set to expand at a CAGR of 4.10% through 2034. Crucial factors raising the sales of disinfection caps are as follows:
Country | Germany |
---|---|
Forecast CAGR % (2024 to 2034) | 3.6% |
Germany is projected to be an important market for disinfection caps in Europe. The country is set to accelerate through the forecast period at a 3.6% CAGR. Given below are the leading components that are driving the German market:
Country | China |
---|---|
Forecast CAGR % (2024 to 2034) | 5.5% |
In China, the disinfection cap market is projected to expand at a greater rate of 5.5% CAGR than its counterparts. This can be attributed to the considerable and rapidly growing population as well as medical incidences in the country. As a result, manufacturers are scouting for opportunities in China. Other factors that are consolidating China’s position on a global scale are as follows:
Country | India |
---|---|
Forecast CAGR % (2024 to 2034) | 4.9% |
India is projected to emerge as a steadfast player in the overall disinfection cap market. As per analysis, the market is projected to be driven at a 4.9% CAGR through 2034. Players are traversing boundaries to possess a larger consumer base. Other factors increasing the sales of medical disinfection caps are as follows:
Country | Australia |
---|---|
Forecast CAGR % (2024 to 2034) | 4.60% |
Australia is forecast to expand at a CAGR of 4.60% through 2034. Key factors pulling the market’s growth are listed below:
Leading End Use | Hospitals |
---|---|
Value Share % (2024) | 38.80% |
The hospital segment is projected to acquire a prominent market share of 38.80% in 2024. Considerable patient footfall in hospitals is raising the share of this segment in the disinfection cap market. Increasing utilization of intravenous connectors and catheters for multiple purposes like blood transfusion, parenteral nutrition, dialysis, etc., is pushing product demand. Additionally, mounting healthcare expenditure to develop more hospitals is favoring sales of disinfection caps.
Leading Distribution Channel | Non-retail |
---|---|
Value Share % (2024) | 63.80% |
The non-retail segment is anticipated to obtain a 63.80% share of the global market in 2024. Non-retail distribution of disinfection caps has become a norm as hospitals and clinics usually come into long-term contracts and alliances with distributors and manufacturers. The rising count of group purchasing organizations (GPOs) that accumulate purchasing power of multiple healthcare facilities is also contributing to this segment's growth. This gives them bargaining power to negotiate a lower price for disinfection caps with manufacturers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market leaders in the disinfection cap industry are zeroing in on organic growth tactics like new product developments and product approvals. These steps are expected to forward participants' revenue and clientele in the disinfection cap market. Market distributors are deploying their resources to lead to innovations in disinfection cap technology. The widened product portfolio is anticipated to raise companies' revenue generation.
Disinfection cap players ceaselessly invest in research and development to advance the market's growth. Inorganic growth strategies employed by players include acquisitions, collaborations, and partnerships.
Key Developments Favoring the Growth of the Disinfection Cap Market
Company Name | Company Particulars |
---|---|
3M Company | It is an American MNC that works in the fields of healthcare, worker safety, and consumer goods. The company has a culture of innovation and applies science to life. The company caters to numerous industries, such as automotive, health care, electronics, consumer markets, etc. |
Becton Dickinson and Company | It is a global med-tech company. The company is advancing the world of health by launching innovative technology, solutions, and services for healthcare practitioners and patients. |
ICU Medical Inc. | It is a California-based company that operates globally. The company designs products aiming to prevent bloodstream infections and safeguard healthcare workers from exposure to hazardous drugs or infectious diseases. |
B. Braun Melsungen AG | B. Braun Melsungen AG is a German company that delivers medical and pharmaceutical devices. Presently, the company has over 63,000 employees internationally, with production facilities and offices in over 60 countries. |
Baxter International Inc. | It is a healthcare MNC with headquarters in Deerfield, Illinois. The firm focuses on products that treat kidney diseases and other acute and chronic medical conditions. The company is pursuing healthcare transformation to help providers and patients beat the challenges they face. |
The disinfection cap market is expected to be worth US$ 376.8 million in 2024.
The market is predicted to expand at a CAGR of 4.5% through 2034.
The market is anticipated to account for US$ 585.1 million by 2034.
China is predicted to provide high growth opportunities.
Hospitals acquire a leading share, with an estimated share of 38.80% in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034 5.3.1. Non-retail 5.3.2. Retail 5.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034 6.3.1. Hospitals 6.3.2. Clinics 6.3.3. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Distribution Channel 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Distribution Channel 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Distribution Channel 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Distribution Channel 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Distribution Channel 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Distribution Channel 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Distribution Channel 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Distribution Channel 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Distribution Channel 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Distribution Channel 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Distribution Channel 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Distribution Channel 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Distribution Channel 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Distribution Channel 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2023 15.1.2.1. By Distribution Channel 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2023 15.2.2.1. By Distribution Channel 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2023 15.3.2.1. By Distribution Channel 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2023 15.4.2.1. By Distribution Channel 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2023 15.5.2.1. By Distribution Channel 15.5.2.2. By End User 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2023 15.6.2.1. By Distribution Channel 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2023 15.7.2.1. By Distribution Channel 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2023 15.8.2.1. By Distribution Channel 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2023 15.9.2.1. By Distribution Channel 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2023 15.10.2.1. By Distribution Channel 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2023 15.11.2.1. By Distribution Channel 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2023 15.12.2.1. By Distribution Channel 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2023 15.13.2.1. By Distribution Channel 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2023 15.14.2.1. By Distribution Channel 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2023 15.15.2.1. By Distribution Channel 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2023 15.16.2.1. By Distribution Channel 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2023 15.17.2.1. By Distribution Channel 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2023 15.18.2.1. By Distribution Channel 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2023 15.19.2.1. By Distribution Channel 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2023 15.20.2.1. By Distribution Channel 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2023 15.21.2.1. By Distribution Channel 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2023 15.22.2.1. By Distribution Channel 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2023 15.23.2.1. By Distribution Channel 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Distribution Channel 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Becton, Dickinson and Company 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. 3M Company 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. ICU Medical 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Merit Medical 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Agilent Technologies, Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. B. Braun Melsungen AG 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Thermo Fisher Scientific, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Biocrates Life Sciences AG 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Excelsior Medical LLC 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Henry Schein 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. JCM MED 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Chemicals & Materials
April 2023
REP-GB-17014
423 pages
Explore Consumer Product Insights
View Reports